DSM-5 Changes, COVID-19, and ADHD Diagnosis Rates in Individuals Younger Than 30 Years

Zishan Cui; Anshula Ambasta; Wade Thompson; Ken Bassett; Greg Carney; Colin R. Dormuth

doi:10.1001/jamanetworkopen.2026.5775

April 8, 2026JAMA Network OpenOpen Access

DSM-5 Changes, COVID-19, and ADHD Diagnosis Rates in Individuals Younger Than 30 Years

View Full Paper

Ask AI

Bookmark

Share

Key Points

To investigate how changes in diagnostic criteria and the COVID-19 pandemic affected ADHD diagnosis rates in youth under 30.
Conducted a cohort study in British Columbia.
Analyzed ADHD diagnosis rates pre- and post-DSM-5 changes.
Monitored trends before and during the COVID-19 pandemic.
Observed variations in ADHD diagnosis rates among youth.
Noted an increase in diagnoses correlating with DSM-5 changes and the pandemic.
Identified significant patterns in diagnoses related to the timing of assessments.

Implication

Cohort study examines changes in ADHD diagnosis rates in youth, highlighting the influence of DSM-5 alterations and the COVID-19 pandemic.

Abstract

This cohort study of youth in British Columbia examines changes in attention-deficit/hyperactivity disorder diagnosis rates following changes in Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) and the COVID-19 pandemic.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cui et al. (2026) studied this question.

synapsesocial.com/papers/69d896046c1944d70ce072fe https://doi.org/10.1001/jamanetworkopen.2026.5775

View Full Paper

Ask AI

Bookmark

Share

DSM-5 Changes, COVID-19, and ADHD Diagnosis Rates in Individuals Younger Than 30 Years

Key Points

Implication

Abstract

Discussion

Cite This Study

DSM-5 Changes, COVID-19, and ADHD Diagnosis Rates in Individuals Younger Than 30 Years

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading